Clinical experience in treatment of thrombotic thrombocytopenic purpura - hemolytic uremic syndrome with 28 patients | Zendy

D. Vučelić | Zendy; Zoran Rajić | Zendy; Nebojša Savić | Zendy; Danijela Miković | Zendy; Zivko Budisin | Zendy; Nebojša Antonijević | Zendy; Slobodan Obradović | Zendy; Dragana Jevtić | Zendy; Giuseppe Bettoni | Zendy; Gloria Casoli | Zendy; Flora Peyvandi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical experience in treatment of thrombotic thrombocytopenic purpura - hemolytic uremic syndrome with 28 patients

Author(s) -

D. Vučelić,

Zoran Rajić,

Nebojša Savić,

Danijela Miković,

Zivko Budisin,

Nebojša Antonijević,

Slobodan Obradović,

Dragana Jevtić,

Giuseppe Bettoni,

Gloria Casoli,

Flora Peyvandi

Publication year - 2013

Publication title -

acta chirurgica iugoslavica

Language(s) - English

Resource type - Journals

eISSN - 2406-0887

pISSN - 0354-950X

DOI - 10.2298/aci1301029v

Subject(s) - adamts13 , thrombotic thrombocytopenic purpura , medicine , exacerbation , gastroenterology , microangiopathic hemolytic anemia , platelet , von willebrand factor

Neither optimal treatment nor significance of ADAMTS13 (A Desintegrin And Metalloprotease with ThromboSpondin type 1 repeats) activity for diagnosis and therapy of thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) have not been defined yet. The aim of the report is to analyze response to different volumes of plasma exchange (PE), and relationship to ADAMTS13.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research